患有SLE的中年和老年人对衰老的看法:单中心横截面研究
Sarah B Lieber1,2, Yvonne Shea3, Sarah P Gottesman3
1Division of Rheumatology, Hospital for Special Surgery, New York City, New York, USA LieberS@hss.edu.
Lupus science & medicine
|October 1, 2025
概括
对衰老的负面自我认知与SLE成年人的生活质量低下有关. 解决这些负面观点可能会改善这个患者群体的与健康有关的生活质量.
科学领域:
- 类风湿病学 类风湿病学
- 老年学是一门学科.
- 心理学 心理学 心理学
背景情况:
- 对衰老的负面自我认知与老年人健康相关生活质量 (HRQoL) 的降低相关.
- 系统性红斑狼 (SLE) 是一种慢性自身免疫性疾病,影响多个器官.
- 了解影响SLE老年患者HRQoL的因素对于有效管理至关重要.
研究的目的:
- 调查积极和负面的自我认知与中年和老年SLE成年人的衰老和结果之间的联系.
- 检查SLE患者对衰老的自我认知与疼痛,抑郁,残疾和虚弱之间的关系.
- 确定干预措施的潜在目标,以改善这一群体的HRQoL.
主要方法:
- 对50岁及以上确诊SLE的成年人进行横截面研究.
- 使用与年龄有关的变化意识 (AARC) 尺度评估老龄化的自我感知.
- 测量结果包括疼痛干扰,抑郁,残疾和虚弱,使用验证的仪器 (PROMIS-29,VLA,FRAIL尺度).
主要成果:
- 对衰老的负面自我认知 (AARC损失) 与增加的疼痛干扰,抑郁和虚弱显著相关.
- 对衰老的积极 (AARC收益) 和消极 (AARC损失) 自我认知都与残疾有关.
- 积极的自我认知与疼痛,抑郁或虚弱之间没有发现显著的关联.
结论:
- 对衰老的负面自我认知是SLE中年和老年人HRQoL下降的独立预测因素.
- 针对负面自我认知衰老的干预措施可能会提高SLE患者的HRQoL.
- 需要进行进一步的研究,以探索将衰老的自我感知与SLE的健康结果联系在一起的机制.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
Cognitive Development During Adulthood
780
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
780
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
228
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
228
Longitudinal Research
13.1K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.1K
Drug Dosing: Geriatric Patients
227
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
227
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
237
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
237


